KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Assets Average: 2018-2025

Historic Assets Average for Amneal Pharmaceuticals (AMRX) over the last 7 years, with Sep 2025 value amounting to $3.5 billion.

  • Amneal Pharmaceuticals' Assets Average rose 0.74% to $3.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 billion, marking a year-over-year increase of 0.74%. This contributed to the annual value of $3.5 billion for FY2024, which is 4.10% down from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Assets Average stood at $3.5 billion for Q3 2025, which was up 3.46% from $3.4 billion recorded in Q2 2025.
  • Amneal Pharmaceuticals' 5-year Assets Average high stood at $4.0 billion for Q3 2021, and its period low was $3.4 billion during Q2 2025.
  • Moreover, its 3-year median value for Assets Average was $3.5 billion (2024), whereas its average is $3.5 billion.
  • In the last 5 years, Amneal Pharmaceuticals' Assets Average decreased by 7.60% in 2023 and then grew by 0.74% in 2025.
  • Amneal Pharmaceuticals' Assets Average (Quarterly) stood at $4.0 billion in 2021, then dropped by 3.04% to $3.8 billion in 2022, then decreased by 6.69% to $3.6 billion in 2023, then declined by 2.75% to $3.5 billion in 2024, then climbed by 0.74% to $3.5 billion in 2025.
  • Its last three reported values are $3.5 billion in Q3 2025, $3.4 billion for Q2 2025, and $3.4 billion during Q1 2025.